| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.15 | 0.1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |